Straumann Holding Resultados de beneficios anteriores
Pasado controles de criterios 1/6
Straumann Holding ha aumentado sus beneficios a una tasa media anual de 10.6%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 10.6% anual. Los ingresos han ido creciendo a una tasa media de 12.7% al año. La rentabilidad financiera de Straumann Holding es de 14.7%, y sus márgenes netos son de 11.3%.
Información clave
10.6%
Tasa de crecimiento de los beneficios
10.5%
Tasa de crecimiento del BPA
Crecimiento de la industria Medical Equipment | 11.1% |
Tasa de crecimiento de los ingresos | 12.7% |
Rentabilidad financiera | 14.7% |
Margen neto | 11.3% |
Próxima actualización de resultados | 19 Feb 2025 |
Actualizaciones de resultados anteriores recientes
Recent updates
Investors Shouldn't Overlook The Favourable Returns On Capital At Straumann Holding (VTX:STMN)
Oct 31Straumann Holding (VTX:STMN) Has A Pretty Healthy Balance Sheet
Oct 18Is Straumann Holding (VTX:STMN) A Risky Investment?
Jun 04Calculating The Fair Value Of Straumann Holding AG (VTX:STMN)
Apr 29Straumann Holding AG's (VTX:STMN) P/S Still Appears To Be Reasonable
Apr 15Is Now The Time To Look At Buying Straumann Holding AG (VTX:STMN)?
Mar 18Straumann Holding (VTX:STMN) Is Reinvesting At Lower Rates Of Return
Feb 29Straumann Holding AG's (VTX:STMN) Popularity With Investors Is Clear
Jan 09When Should You Buy Straumann Holding AG (VTX:STMN)?
Nov 26Straumann Holding (VTX:STMN) Knows How To Allocate Capital
Nov 12Straumann Holding (VTX:STMN) Seems To Use Debt Quite Sensibly
Oct 03Calculating The Intrinsic Value Of Straumann Holding AG (VTX:STMN)
Sep 02Is It Too Late To Consider Buying Straumann Holding AG (VTX:STMN)?
Aug 18Why You Should Care About Straumann Holding's (VTX:STMN) Strong Returns On Capital
Aug 04Here's Why We Think Straumann Holding (VTX:STMN) Might Deserve Your Attention Today
Jul 18Straumann Holding (VTX:STMN) Has A Rock Solid Balance Sheet
Jun 18Is Now An Opportune Moment To Examine Straumann Holding AG (VTX:STMN)?
May 07Straumann Holding (VTX:STMN) Is Reinvesting To Multiply In Value
Apr 23Do Straumann Holding's (VTX:STMN) Earnings Warrant Your Attention?
Apr 07We Think Straumann Holding (VTX:STMN) Can Manage Its Debt With Ease
Mar 11Capital Investments At Straumann Holding (VTX:STMN) Point To A Promising Future
Jan 15Is Now The Time To Put Straumann Holding (VTX:STMN) On Your Watchlist?
Dec 11When Should You Buy Straumann Holding AG (VTX:STMN)?
Nov 27Many Would Be Envious Of Straumann Holding's (VTX:STMN) Excellent Returns On Capital
Oct 17Straumann Holding (VTX:STMN) Seems To Use Debt Rather Sparingly
Oct 03Do Straumann Holding's (VTX:STMN) Earnings Warrant Your Attention?
Sep 07When Should You Buy Straumann Holding AG (VTX:STMN)?
Aug 22Investors Shouldn't Overlook The Favourable Returns On Capital At Straumann Holding (VTX:STMN)
Jul 08Straumann Holding (VTX:STMN) Could Easily Take On More Debt
Jun 23Should You Be Adding Straumann Holding (VTX:STMN) To Your Watchlist Today?
May 26Is Straumann Holding AG (VTX:STMN) Potentially Undervalued?
May 12Straumann Holding (VTX:STMN) Looks To Prolong Its Impressive Returns
Mar 30These 4 Measures Indicate That Straumann Holding (VTX:STMN) Is Using Debt Safely
Mar 15I Ran A Stock Scan For Earnings Growth And Straumann Holding (VTX:STMN) Passed With Ease
Feb 18At CHF1,525, Is Straumann Holding AG (VTX:STMN) Worth Looking At Closely?
Feb 02Straumann Holding (VTX:STMN) Has A Rock Solid Balance Sheet
Dec 10Capital Investments At Straumann Holding (VTX:STMN) Point To A Promising Future
Nov 05What Does Straumann Holding AG's (VTX:STMN) Share Price Indicate?
Oct 19Is Straumann Holding (VTX:STMN) Using Too Much Debt?
Aug 29Straumann Holding (VTX:STMN) Will Be Hoping To Turn Its Returns On Capital Around
Jul 26Is Straumann Holding AG (VTX:STMN) Potentially Undervalued?
Jul 05Desglose de ingresos y gastos
Cómo gana y gasta dinero Straumann Holding. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
30 Jun 24 | 2,541 | 288 | 1,255 | 0 |
31 Mar 24 | 2,477 | 267 | 1,229 | 0 |
31 Dec 23 | 2,412 | 246 | 1,204 | 0 |
30 Sep 23 | 2,313 | 330 | 1,155 | 0 |
30 Jun 23 | 2,286 | 394 | 1,175 | 0 |
31 Mar 23 | 2,304 | 415 | 1,194 | 0 |
31 Dec 22 | 2,321 | 435 | 1,212 | 0 |
30 Sep 22 | 2,268 | 462 | 1,157 | 0 |
30 Jun 22 | 2,215 | 489 | 1,102 | 0 |
31 Mar 22 | 2,118 | 442 | 1,053 | 0 |
31 Dec 21 | 2,022 | 396 | 1,004 | 0 |
30 Sep 21 | 1,914 | 377 | 929 | 0 |
30 Jun 21 | 1,806 | 358 | 855 | 0 |
31 Mar 21 | 1,616 | 224 | 793 | 0 |
31 Dec 20 | 1,426 | 91 | 731 | 0 |
30 Sep 20 | 1,424 | 79 | 741 | 0 |
30 Jun 20 | 1,421 | 67 | 751 | 0 |
31 Mar 20 | 1,509 | 187 | 776 | 0 |
31 Dec 19 | 1,596 | 306 | 801 | 0 |
30 Sep 19 | 1,529 | 298 | 769 | 0 |
30 Jun 19 | 1,462 | 289 | 737 | 0 |
31 Mar 19 | 1,413 | 281 | 708 | 0 |
31 Dec 18 | 1,364 | 273 | 680 | 0 |
30 Sep 18 | 1,307 | 271 | 652 | 0 |
30 Jun 18 | 1,250 | 269 | 624 | 0 |
31 Mar 18 | 1,181 | 274 | 592 | 0 |
31 Dec 17 | 1,112 | 280 | 561 | 0 |
30 Sep 17 | 1,056 | 257 | 544 | 0 |
30 Jun 17 | 1,000 | 235 | 528 | 0 |
31 Mar 17 | 959 | 232 | 511 | 0 |
31 Dec 16 | 918 | 230 | 494 | 0 |
30 Sep 16 | 889 | 218 | 483 | 0 |
30 Jun 16 | 861 | 207 | 473 | 0 |
31 Mar 16 | 830 | 139 | 459 | 0 |
31 Dec 15 | 799 | 71 | 445 | 0 |
30 Sep 15 | 774 | 79 | 434 | 0 |
30 Jun 15 | 750 | 88 | 423 | 0 |
31 Mar 15 | 730 | 123 | 418 | 0 |
31 Dec 14 | 710 | 158 | 413 | 0 |
30 Sep 14 | 697 | 137 | 416 | 0 |
30 Jun 14 | 684 | 116 | 418 | 0 |
31 Mar 14 | 682 | 109 | 421 | 0 |
31 Dec 13 | 680 | 101 | 424 | 0 |
Ingresos de calidad: STMN tiene una única gran pérdida de CHF171.4M que afecta a sus resultados financieros de los últimos 12 meses de 30th June, 2024.
Margen de beneficios creciente: Los actuales márgenes de beneficio(11.3%) de STMN son inferiores a los del año pasado (17.3%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de STMN han crecido un 10.6% al año en los últimos 5 años.
Acelerando crecimiento: STMN ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: STMN tuvo un crecimiento negativo de los beneficios (-27%) durante el año pasado, lo que dificulta la comparación con la media de la industria Medical Equipment (-2.2%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de STMN (14.7%) se considera baja.